Does Rhabdomyolysis Cause Hyperkalemia? Yes, Here’s How

Yes, rhabdomyolysis directly causes hyperkalemia (high blood potassium). When muscle cells break down, they release large amounts of potassium into the bloodstream. About 31% of patients with traumatic rhabdomyolysis develop clinically significant hyperkalemia, making it one of the most common and dangerous complications of the condition.

Why Damaged Muscles Flood the Blood With Potassium

Muscle cells hold the largest reserve of potassium in your body. Under normal conditions, potassium stays locked inside cells at concentrations roughly 30 times higher than what circulates in your blood. When rhabdomyolysis destroys muscle tissue, those cells rupture and dump their contents, including potassium, into the bloodstream all at once. The more muscle that breaks down, the larger the potassium surge.

Your kidneys are normally capable of filtering out excess potassium, but rhabdomyolysis often overwhelms that system too. Myoglobin, the oxygen-carrying protein inside muscle cells, is also released during the breakdown. In the kidneys, myoglobin constricts blood vessels, damages the cells lining the kidney’s filtering tubes, and can physically clog those tubes by forming precipitates, especially when urine is acidic. This combination of effects can trigger acute kidney injury, which impairs the kidneys’ ability to excrete potassium. So the body faces a double hit: a massive influx of potassium and a reduced ability to get rid of it.

Potassium Levels and Kidney Function

Whether hyperkalemia becomes life-threatening depends largely on how well the kidneys are holding up. Research shows that potassium and calcium levels in rhabdomyolysis patients correlate more closely with the severity of kidney failure than with peak levels of creatine kinase (the standard blood marker used to measure muscle damage). In other words, a person with moderate muscle breakdown but significant kidney injury may face worse hyperkalemia than someone with massive muscle damage whose kidneys are still functioning. That said, the risk of both kidney failure and electrolyte disturbances rises substantially when creatine kinase levels exceed 15,000 U/L.

Rhabdomyolysis also creates metabolic acidosis, a buildup of acid in the blood. Acidosis makes hyperkalemia worse because it causes potassium to shift out of cells and into the bloodstream, adding to the already elevated levels.

How Hyperkalemia Affects the Heart

The reason hyperkalemia is treated as a medical emergency is its effect on the heart. Potassium controls the electrical signals that keep the heart beating in rhythm, and elevated levels progressively disrupt that system.

Hyperkalemia is classified by severity: mild at 5.5 to 6.0 mEq/L, moderate at 6.1 to 7.0, and severe above 7.0. The heart changes follow a predictable progression. Early on, the T waves on an ECG become tall and peaked. As levels climb, the P waves flatten and the interval between heartbeats lengthens. At moderate levels, the P waves may disappear entirely. In severe hyperkalemia, the QRS complex (the main electrical signal representing each heartbeat) widens dramatically, eventually producing a sine wave pattern on the monitor. This can deteriorate into ventricular fibrillation or complete cardiac standstill. The mortality rate for severe hyperkalemia that isn’t treated quickly is around 67%.

How It Compares to Other Electrolyte Problems in Rhabdomyolysis

Hyperkalemia is not the only electrolyte disturbance rhabdomyolysis causes, but it is the most immediately dangerous. A 2024 systematic review and meta-analysis of traumatic rhabdomyolysis patients found the following rates of electrolyte imbalances:

  • Low calcium (hypocalcemia): 57%, the most common
  • High phosphate (hyperphosphatemia): 33%
  • High potassium (hyperkalemia): 31%
  • Low sodium (hyponatremia): 23%

Low calcium is actually more prevalent, but hyperkalemia poses a more immediate threat to survival because of its direct effects on cardiac rhythm. In practice, these imbalances often occur together and can compound each other’s effects.

How Hyperkalemia Is Managed in Rhabdomyolysis

Treatment works on two tracks: protecting the heart immediately and lowering potassium levels over the next several hours.

The first priority is stabilizing the heart’s electrical activity. Intravenous calcium is given to counteract potassium’s effect on heart cells. It works within one to two minutes but only lasts 30 to 60 minutes, so it buys time rather than solving the problem. Next, insulin paired with glucose is given intravenously. The insulin drives potassium back into cells, lowering blood levels by 0.5 to 1.5 mEq/L over the next two to six hours. The glucose prevents blood sugar from dropping dangerously low.

If hyperkalemia is refractory, meaning it doesn’t respond to these measures, or if the kidneys have failed significantly, dialysis becomes necessary. Dialysis directly removes potassium from the blood and is often the definitive treatment in severe rhabdomyolysis cases with kidney injury.

Aggressive intravenous fluids, the cornerstone of rhabdomyolysis treatment overall, also help by increasing urine output, flushing myoglobin from the kidneys, and allowing the body to excrete more potassium naturally. This is why early, high-volume fluid resuscitation is critical: it addresses both the kidney damage and the electrolyte disturbances simultaneously.